An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

Summary

The bill updates the state's Controlled Substance, Drug, Device and Cosmetic Act by creating new scheduling categories for certain drugs and requiring secure storage of xylazine. It also adds specific rules concerning the use of medetomidine. These changes aim to improve oversight of these substances.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share